Human Metapneumovirus (hMPV) Diagnosis: Advanced Techniques and Best Practices for Accurate Detection
Human metapneumovirus (hMPV) was first
identified in 2001 by Bernadette G. van den Hoogen and colleagues in the
Netherlands. Since its identification, it has been a major cause of respiratory
infections worldwide. It is a negative-sense single-stranded RNA virus that
infects the upper and lower respiratory tract, including the lungs. Its
infection shows symptoms ranging from mild cold-like symptoms to more severe
conditions such as pneumonia and bronchitis. As with any other disease, early
and accurate diagnosis is crucial for effective patient management outbreak
control and reducing unnecessary antibiotic use. In this article, we will explore
the latest diagnostic techniques, challenges and best practices for detecting
hMPV.
 |
| Diagnostic Techniques of Human Metapneumovirus (hMPV) |
Why hMPV Diagnosis Matters
The symptoms of HMPV such as cough,
fever, nasal congestion and wheezing often resemble those of other respiratory
viral infections such as influenza, RSV and the common cold. Misdiagnosis can
delay treatment, worsen the patient's health condition and worsen the
infection. Early identification through reliable diagnostic methods ensures
timely care.
Clinical Symptoms and Diagnosis of hMPV
It is important to understand the
common symptoms associated with hMPV infection before proceeding towards
laboratory diagnosis as they guide doctors and healthcare providers to suspect
the virus in patients.
Clinical symptoms of hMPV infection:
• Upper respiratory symptoms: The
infected individual may show runny nose, sore throat, cough, and sneezing.
• Lower respiratory symptoms: With the
increase in the intensity of HMPV, the patient may show more severe problems,
such as wheezing, shortness of breath, chest pain, and difficulty in breathing.
This may lead to bronchiolitis or pneumonia.
• Other symptoms: Symptoms such as
mild or high fever, fatigue, and headache are also commonly reported, depending
on the severity of the infection.
Viral infections, especially those
related to the respiratory system, are more common during the cold season. When
a patient visits a doctor or healthcare provider with respiratory symptoms,
hMPV may be suspected if the symptoms resemble other viral respiratory
illnesses such as respiratory syncytial virus (RSV), influenza, or the common
cold. However, laboratory testing is needed for a definitive diagnosis.
Advanced Diagnostic Techniques for hMPV
In the current era, there are several
diagnostic tests available that confirm the presence of hMPV in an infected
individual. Laboratory tests require sample material for analysis such as swabs
taken from the nose and throat, sputum or bronchoalveolar lavage (BAL) fluid.
These tests can directly detect the virus in the collected sample or detect it
by identifying the genetic material. The most common methods for diagnosing
hMPV are as follows:
Molecular Testing: Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
How RT-PCR works for hMPV diagnosis:
• Tissue sample is collected using a
cotton swab from the infected respiratory tract of the patient (e.g. nose or
throat swab).
• Genetic material (RNA) is extracted
from the collected sample.
• The extracted RNA is converted into
complementary DNA (cDNA) by the process of reverse transcription as hMPV is an
RNA virus.
• This DNA is amplified by polymerase
chain reaction (PCR) to detect the genetic material of the virus.
• This amplified DNA is matched with
the verified sample of hMPV DNA, if it matches then the report is positive for hMPV
virus otherwise negative.
 |
| Rapid Antigen Test (RAT) Vs RT-PCR Accuracy Comparison |
Antigen Detection Test: RAT (Rapid Antigen Test)
This
test is faster and cheaper than a RT-PCR test and is used as an initial
screening during outbreaks. Rapid antigen tests (RATs) detect hMPV proteins in
respiratory samples.
Antibody tests (serological tests): Immunofluorescence assay (IFA)
This
is a technique that is based on the fact that the cells of the human body
produce special proteins called antibodies (IgM and IgG) or interferons when
attacked by any virus. These antibodies are released in the body system. These
antibodies bind to the surface proteins of the infecting virus and render them
ineffective. This IFA technique uses these antibodies to detect specific viral
proteins in a patient's respiratory sample. In this test, antibodies that
specifically bind to hMPV proteins (such as nucleoprotein or glycoprotein) are
used. Once the antibodies bind to the virus, they are tagged with a fluorescent
dye.
How IFA works:
•
A sample of infected tissue is collected from the patient's respiratory tract
(e.g., nasopharyngeal swab) and smeared on a slide.
•
The material on the slide is then treated with fluorescent-labeled antibodies
that are specific for hMPV.
•
If hMPV is present in the sample, the hMPV-specific antibodies will bind to the
surface proteins of the hMPV virus and form a complex. This antibody and viral
protein complex will glow in a special light.
•
The presence of this fluorescent area on the slide indicates that the patient
is positive for hMPV infection.
The
IFA technique is less commonly used because it requires a skilled laboratory
technician and special equipment to detect the fluorescent reaction. These
tests are useful for epidemiological studies but are less effective for rapid
diagnosis because of the delay in antibody response.
Antibody Tests (Serological Tests): Direct Fluorescent Antibody (DFA) Test
The
direct fluorescent antibody (DFA) test is a technique that provides quick
results. It is similar to the immunofluorescence assay test; The only
difference is that it involves the direct application of fluorescent-labeled
antibodies on a respiratory sample collected from an infected person.
How DFA works:
•
A sample from an infected person is collected from the respiratory tract (such
as a nasal or throat swab) and a slide is prepared.
•
hMPV-specific fluorescently labeled antibodies are added directly to the sample
on the slide.
•
If hMPV is present in the sample, the labeled antibodies bind to the HMPV
virus. It starts emitting fluorescent rays when viewed under ultraviolet light.
 |
| Difference Between IFA and DFA Testing Technique for hMPV |
Enzyme-linked immunosorbent assay (ELISA)
This
test is different from the other tests mentioned above. The enzyme-linked
immunosorbent assay test confirms the presence of viral infection by confirming
the presence of antibodies produced by the patient's immune system to fight the
virus. To test hMPV infection, a blood sample or tissue is collected from the
infected part and tested for the presence of antibodies in it. The procedure is
as follows:
How ELISA works:
•
Infected respiratory tissue or blood sample is collected from the patient's
body and applied to a surface coated with virus antigen.
•
If the virus or antibodies produced against the virus by the infected body are
present in the sample, an enzyme is triggered to cause a color change,
indicating a positive result.
The
ELISA test is not the first choice for diagnosing acute hMPV patients. It is
usually used in research settings or for serological surveys (to study past
infections).
Viral
culture
In
viral culture test, the sample taken from the patient is placed in a culture
medium containing host cells along with cells that support viral growth. If the
virus is present in the sample, it will grow and infect the cells present in
the culture medium and then the virus can be detected.
How viral culture works:
•
The sample is collected and placed in a culture medium containing host cells.
•
If the virus is present, it will infect the cells and replicate, eventually
causing observable changes (cytopathic effects) in the cells.
•
The virus is then identified using specific tests like PCR or IFA.
The
viral culture technique is rarely used for routine HMPV diagnostic tests as it
is a time-consuming process and requires specialized laboratory facilities. It
is less efficient than molecular methods like PCR.
Rapid diagnostic tests (RDTs)
Some
rapid diagnostic tests (RDTs) are also commercially available that can detect
hMPV quickly, especially in urgent clinical situations. These tests typically
use lateral flow immunoassay technology to detect viral antigens in respiratory
samples.
How RDTs work:
•
The respiratory
sample is placed on a commercially available test strip coated with antibodies
that bind to the hMPV antigen.
•
If the virus is present, the antigen will bind to the antibody, causing a
visible color change on the test strip.
RDTs
are quick and easy to use, providing results in 15 to 30 minutes. However, they
are less sensitive and specific than PCR, meaning that false negatives or
positives are also possible.
Imaging (X-ray/MRI):
In
severe cases, chest X-ray or MRI and other imaging techniques may be useful to
assess the extent of respiratory tract congestion and damage. 5. Differential
diagnosis: The symptoms of hMPV overlap with other respiratory infections, such
as pneumonia, bronchitis, etc. The doctor or healthcare provider may use a
multiplex PCR assay or perform additional tests to rule out other causes, such
as influenza, respiratory syncytial virus (RSV), and COVID-19.
When to get diagnosed
Like
other infectious diseases, early diagnosis and proper care and management of
the hMPV virus can help prevent complications. Therefore, if you or someone you
know experiences the following complications, it is best to consult a doctor or
healthcare professional for medical evaluation:
•
Persistent or severe symptoms, such as difficulty breathing, high fever, or
wheezing.
•
Symptoms that get worse or do not improve with home care.
•
Risk factors such as being very young, elderly, or having a weakened immune
system.
Conclusion
The
diagnosis of human metapneumovirus (hMPV) requires a combination of clinical
evaluation and laboratory testing. While clinical symptoms provide an initial
indication of infection, laboratory tests such as PCR, IFA, DFA, and ELISA
provide a definitive diagnosis. Rapid diagnostic tests are also available for
quick results, although they may not be as accurate as more specialized
laboratory techniques. Accurate and early diagnosis of hMPV is critical for
effective patient management, particularly in vulnerable populations. As hMPV
gains recognition as a major respiratory pathogen, improving access to
molecular diagnostics and physician awareness is critical to enhance patient
care and outbreak response. By prioritizing accuracy and access to hMPV
diagnostics, healthcare providers can reduce misdiagnosis and improve outcomes
for vulnerable populations.
Frequently Asked Questions (FAQs)
Which test is most accurate for hMPV?
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is the gold standard due to its high accuracy and sensitivity but it requires specialized equipment and trained personnel. Rapid antigen tests are faster and mostly used in outbreak conditions but may miss infections with low viral loads.
Can hMPV be diagnosed at home?
Currently, no FDA-approved home tests exist. For diagnosis, you have to depend on clinical evaluation and lab testing.
Why is hMPV often misdiagnosed?
The clinical symptoms of hMPV often mimic other respiratory infection-causing viruses like flu, common cold and RSV. Many regions of the world lack access to advanced testing like PCR also leads to misdiagnosis. Hence, clinical awareness regarding symptoms is critical.
Are there specific treatments for hMPV?
To date no specific antiviral drugs that target hMPV are available. Treatment focuses on symptom relief (e.g., oxygen, hydration). Accurate diagnosis prevents unnecessary intake of antibiotics.
When should high-risk patients seek testing?
High-risk patients like infants, elderly and Immunocompromised individuals or those with severe symptoms (e.g., difficulty breathing) should seek immediate care for testing.
How long does hMPV testing take?
RT-PCR results typically take 24–48 hours. Rapid antigen tests (RAT) provide results in 15–30 minutes but are less reliable.
 Diagnosis: Advanced Techniques and Best Practices for Accurate Detection ){kind=link}